{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T15:03:33Z","timestamp":1772463813811,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T00:00:00Z","timestamp":1231891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00702-008-0177-6","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T15:18:59Z","timestamp":1231859939000},"page":"203-212","source":"Crossref","is-referenced-by-count":110,"title":["Combined CSF tau, p-tau181 and amyloid-\u03b2 38\/40\/42 for diagnosing Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"116","author":[{"given":"Volker","family":"Welge","sequence":"first","affiliation":[]},{"given":"Oliver","family":"Fiege","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Lewczuk","sequence":"additional","affiliation":[]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[]},{"given":"Hermann","family":"Esselmann","sequence":"additional","affiliation":[]},{"given":"Hans-Wolfgang","family":"Klafki","sequence":"additional","affiliation":[]},{"given":"Stefanie","family":"Wolf","sequence":"additional","affiliation":[]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[]},{"given":"Markus","family":"Otto","sequence":"additional","affiliation":[]},{"given":"Johannes","family":"Kornhuber","sequence":"additional","affiliation":[]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[]},{"given":"Mirko","family":"Bibl","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,1,14]]},"reference":[{"key":"177_CR1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awl063","volume":"129","author":"M Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Klafki HW, Sparbier K, Smirnov A, Cepek L, Trenkwalder C, R\u00fcther E, Kornhuber J, Otto M, Wiltfang J (2006a) CSF amyloid-\u03b2-peptides in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia. Brain 129:1177\u20131187","journal-title":"Brain"},{"key":"177_CR2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00702-006-0537-z","volume":"113","author":"M Bibl","year":"2006","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Lewczuk P, Trenkwalder C, Brechlin P, R\u00fcther E, Kornhuber J, Otto M, Wiltfang J (2006b) CSF diagnosis of Alzheimer\u2019s disease and dementias with Lewy bodies. J Neural Transm 113:1771\u20131778","journal-title":"J Neural Transm"},{"key":"177_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.mp.4001967","volume":"12","author":"M Bibl","year":"2007","unstructured":"Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Trenkwalder C, Otto M, Stiens G, Ruther E, Kornhuber J, Wiltfang J (2007a) Validation of amyloid-\u03b2 peptides in CSF diagnosis of neurodegenerative dementias. Mol Psy 12:671\u2013680","journal-title":"Mol Psy"},{"key":"177_CR4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00702-006-0618-z","volume":"114","author":"M Bibl","year":"2007","unstructured":"Bibl M, Mollenhauer B, Wolf S, Esselmann H, Lewczuk P, Kornhuber J, Wiltfang J (2007b) Reduced CSF carboxyterminally truncated A\u03b2 petides in frontotemporal lobe degenerations. J Neural Transm 114:621\u2013628","journal-title":"J Neural Transm"},{"key":"177_CR5","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/elps.200305992","volume":"25","author":"M Bibl","year":"2004","unstructured":"Bibl M, Esselmann H, Otto M, Lewczuk P, Cepek L, R\u00fcther E, Kornhuber J, Wiltfang J (2004) Cerebrospinal fluid (CSF) amyloid beta (A\u03b2) peptide patterns in Alzheimer\u2019s disease (AD) patients and non-demented controls depend on sample pre-treatment: Indication of carrier- mediated epitope masking of A\u03b2 peptides. Electrophoresis 25:2912\u20132918","journal-title":"Electrophoresis"},{"key":"177_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000115975","volume":"25","author":"M Bibl","year":"2008","unstructured":"Bibl M, Mollenhauer B, Esselmann H, Schneider M, Lewczuk P, Welge V, Gross M, Falkai P, Kornhuber J, Wiltfang J (2008a) Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review. Dement Geriatr Cogn Disord 25:256\u2013265","journal-title":"Dement Geriatr Cogn Disord"},{"key":"177_CR7","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/prca.200800006","volume":"2","author":"M Bibl","year":"2008","unstructured":"Bibl M, Lewczuk P, Esselmann H, Mollenhauer B, Klafki HW, Welge V, Wolf S, Trenkwalder C, Otto M, Kornhuber J, Wiltfang J (2008b) CSF amyloid-\u03b2 1-38 and 1-42 in FTD and AD: biomarker performance critically depends on the detergent accessible fraction. Proteomics Clin Appl 2:1548\u20131556","journal-title":"Proteomics Clin Appl"},{"key":"177_CR8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1602\/neurorx.1.2.213","volume":"1","author":"K Blennow","year":"2004","unstructured":"Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer\u2019s disease. NeuroRx. 1:213\u2013225","journal-title":"NeuroRx."},{"key":"177_CR9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/gerona\/61.7.755","volume":"61","author":"D Jong De","year":"2006","unstructured":"De Jong D, Jansen RWMM, Kremer BPH, Verbeek MM (2006) Cerebrospinal fluid amyloid \u03b242\/phosphorylated tau ratio discriminates between Alzheimer\u2019s disease and vascular dementia. J Gerontol A Biol Sci Med Sci 61:755\u2013758","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"177_CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51:745\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"177_CR11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"key":"177_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpsyc.61.1.95","volume":"61","author":"H Hampel","year":"2004","unstructured":"Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K (2004) Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer\u2019s disease\u2014a comparative study. Arch Gen Psychiatry 61:95\u2013102","journal-title":"Arch Gen Psychiatry"},{"key":"177_CR13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","volume":"52","author":"F Hulstaert","year":"1999","unstructured":"Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H (1999) Improved discrimination of AD-patients using \u00df-amyloid (1-42) and tau levels in CSF. Neurology 52:1555\u20131562","journal-title":"Neurology"},{"key":"177_CR14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2176\/nmc.44.222","volume":"44","author":"M Ishikawa","year":"2004","unstructured":"Ishikawa M (2004) Guideline committee for idiopathic normal pressure hydrocephalus, Japanese society of normal pressure hydrocephalus. Neurol Med Chir 44:222\u2013223","journal-title":"Neurol Med Chir"},{"key":"177_CR15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410440108","volume":"44","author":"M Kanai","year":"1998","unstructured":"Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, Sasaki H, Abe K, Iwatsubo T, Kosaka T, Watanabe M, Tomidokoro Y, Shizuka M, Mitsushima K, Nakamura T, Igeta Y, Ikeda Y, Amari M, Kawarabayashi T, Ishiguro K, Harigaya Y, Wakabayashi K, Okamoto K, Hirai S, Shoji M (1998) Longitudinal study of cerebrospinal fluid levels of tau, A\u03b21-40, and A\u03b21-42(43) in Alzheimer\u2019s disease: a study in Japan. Ann Neurol 44:17\u201326","journal-title":"Ann Neurol"},{"key":"177_CR16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1899488","volume":"251","author":"VMY Lee","year":"1991","unstructured":"Lee VMY, Balin BJ, Otvos L, Trojanowski JQ (1991) A68. A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251:675\u2013678","journal-title":"Science"},{"key":"177_CR17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1373\/clinchem.2005.058776","volume":"52","author":"P Lewczuk","year":"2006","unstructured":"Lewczuk P, Beck G, Esselmann H, Bruckmoser R, Zimmermann R, Fiszer M, Bibl M, Maler JM, Kornhuber J, Wiltfang J (2006) Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid \u03b2 peptides. Clin Chem 52:332\u2013334","journal-title":"Clin Chem"},{"key":"177_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4580(03)00086-1","volume":"25","author":"P Lewczuk","year":"2004","unstructured":"Lewczuk P, Esselmann H, Otto M, Maler JM, Henkel AW, Henkel MK, Eikenberg O, Antz C, Krause WR, Reulbach U, Kornhuber J, Wiltfang J (2004) Neurochemical diagnosis of Alzheimer\u2019s dementia by CSF Abeta 42, Abeta42\/Abeta40 ratio and total tau. Neurobiol Aging 25:273\u2013281","journal-title":"Neurobiol Aging"},{"key":"177_CR19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/rcm.1048","volume":"17","author":"P Lewczuk","year":"2003","unstructured":"Lewczuk P, Esselmann H, Meyer M, Wollscheid V, Neumann M, Otto M, Maler JM, R\u00fcther E, Kornhuber J, Wiltfang J (2003) The amyloid-\u03b2 (A\u03b2) peptide pattern in cerebrospinal fluid in Alzheimer\u2019s disease: evidence of a novel carboxyterminally elongated A\u03b2 peptide. Rapid Commun Mass Spectrom 17:1291\u20131296","journal-title":"Rapid Commun Mass Spectrom"},{"key":"177_CR20","first-page":"167","volume":"6","author":"I Litvan","year":"1997","unstructured":"Litvan I (1997) Progressive supranuclear palsy and corticobasal degeneration. Baillieres Clin Neurol 6:167\u2013185","journal-title":"Baillieres Clin Neurol"},{"key":"177_CR21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.60.9.1202","volume":"60","author":"A Maddalena","year":"2003","unstructured":"Maddalena A, Papassotiropoulos A, Mueller-Tillmanns B, Jung HH, Hegi T, Nitsch RM, Hock C (2003) Cerebrospinal fluid amyloid \u03b242\/phosphorylated tau ratio discriminates between Alzheimer\u2019s disease and vascular dementia. Arch Neurol 60:1202\u20131206","journal-title":"Arch Neurol"},{"key":"177_CR22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"177_CR23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidlines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113\u20131124","journal-title":"Neurology"},{"key":"177_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000090363","volume":"2","author":"PD Mehta","year":"2005","unstructured":"Mehta PD, Pirttila T (2005) Increased cerebrospinal fluid A beta38\/A beta42 ratio in Alzheimer\u2019s disease. Neurodegener Dis 2:242\u2013245","journal-title":"Neurodegener Dis"},{"key":"177_CR25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, Olson D, Southwick P, Wolfert R, Munroe B, Lieberburg I, Seubert P, Schenk D (1995) Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38:643\u2013648","journal-title":"Ann Neurol"},{"key":"177_CR26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedmann M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobardegeneration. A consensus on clinical diagnostic criteria. Neurology 51:1546\u20131554","journal-title":"Neurology"},{"key":"177_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1099-1166(199804)13:4<203::AID-GPS734>3.0.CO;2-B","volume":"13","author":"D Oslin","year":"1998","unstructured":"Oslin D, Aktinsson RM, Smith DM, Hendrie H (1998) Alcohol related dementia: proposed clinical criteria. Int J Ger Psychiatry 13:203\u2013212","journal-title":"Int J Ger Psychiatry"},{"key":"177_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1212\/WNL.43.2.243","volume":"43","author":"GC Roman","year":"1993","unstructured":"Roman GC, Tatemichi TK, Erkinjutti T, Cummings JL, Masedeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A (1993) Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43:243\u2013245","journal-title":"Neurology"},{"key":"177_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.20508","volume":"58","author":"NS Schoonenboom","year":"2005","unstructured":"Schoonenboom NS, Mulder C, Van Kamp GJ, Mehta SP, Scheltens P, Blankenstein MA, Mehta PD (2005) Amyloid \u03b2 38, 40 and 42 species in cerebrospinal fluid: more of the same? Ann Neurol 58:139\u2013142","journal-title":"Ann Neurol"},{"key":"177_CR30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","volume":"158","author":"M Shoji","year":"1998","unstructured":"Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamuro T, Tomidokoro Y, Shizuka M, Wakabayashi K, Igeta Y, Ikeda Y, Mizushima K, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Hirai S (1998) Combination assay of CSF tau, A\u03b21-40 and A\u03b21-42(43) as a biochemical marker of Alzheimer\u2019s disease. J Neurol Sci 158:134\u2013140","journal-title":"J Neurol Sci"},{"key":"177_CR31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1531-8249(200009)48:3<402::AID-ANA23>3.0.CO;2-G","volume":"48","author":"M Shoji","year":"2000","unstructured":"Shoji M, Matsubara E, Kanai M, Ikeda M, Harigaya Y, Okamoto K, Hirai S (2000) Taps to Alzheimer\u2019s patients: a continuous Japanese study of cerebrospinal fluid biomarkers. Ann Neurol 48:402","journal-title":"Ann Neurol"},{"key":"177_CR32","first-page":"273","volume":"25","author":"M Shoji","year":"2001","unstructured":"Shoji M, Kanai M (2001) Cerebrospinal fluid A\u03b240 and A\u03b242: natural course and clinical usefulness. J Alzheimers Dis 25:273\u2013281","journal-title":"J Alzheimers Dis"},{"key":"177_CR33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0197-4580(00)00229-3","volume":"22","author":"M Shoji","year":"2001","unstructured":"Shoji M, Kanai M, Matsubara E, Tomidokoro Y, Shizuka M, Ikeda Y, Ikeda M, Harigaya Y, Okamoto K, Hirai S (2001) The levels of cerebrospinal fluid A\u03b240 and A\u03b242(43) are regulated age-dependently. Neurobiol Aging 22:209\u2013215","journal-title":"Neurobiol Aging"},{"key":"177_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sj\u00f6gren M, Andreasen N, Blennow K (2000) Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett 285:49\u201352","journal-title":"Neurosci Lett"},{"key":"177_CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","volume":"414","author":"S Weggen","year":"2001","unstructured":"Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414:212\u2013216","journal-title":"Nature"},{"key":"177_CR36","unstructured":"WHO: World Health Organisation (1998) Human transmissible spongiform encephalopathy. Wkly Epidemiol Rec 73:361\u2013365"},{"key":"177_CR37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2006.04404.x","volume":"101","author":"J Wiltfang","year":"2007","unstructured":"Wiltfang J, Esselmann H, Bibl M, H\u00fcll M, Hampel H, Kessler H, Fr\u00f6lich L, Schr\u00f6der J, Peters O, Jessen F, Luckhaus C, Perneczky R, Jahn H, Fiszer M, Maler JM, Zimmermann R, Bruckmoser R, Kornhuber J, Lewczuk P (2007) Amyloid \u03b2 peptide ratio 42\/40 but not A\u03b242 correlates with phospho-tau in patients with low- and high-CSF A\u03b240 load. J Neurochem 101:1053\u20131059","journal-title":"J Neurochem"},{"key":"177_CR38","doi-asserted-by":"crossref","first-page":"42645","DOI":"10.1074\/jbc.M102790200","volume":"276","author":"J Wiltfang","year":"2001","unstructured":"Wiltfang J, Esselmann H, Cupers P, Neumann M, Kretzschmar H, Beyermann M, Schleuder D, Jahn H, R\u00fcther E, Kornhuber J, Anneart W, De Strooper B, Saftig P (2001) Elevation of \u03b2-amyloid peptide 2-42 in sporadic and familial Alzheimer\u2019s disease and its generation in PS1 knockout cells. J Biol Chem 276:42645\u201342657","journal-title":"J Biol Chem"},{"key":"177_CR39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, R\u00fcther E, Kornhuber J (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37\/38\/39 in addition to 1-40\/42 in Alzheimer\u2019s disease and patients with chronic neuroinflammation. J Neurochem. 81:481\u2013496","journal-title":"J Neurochem."},{"key":"177_CR40","first-page":"1448","volume":"313","author":"World Medical Organisation","year":"1996","unstructured":"World Medical Organisation (1996) Declaration of Helsinki. Br Med J 313:1448\u20131449","journal-title":"Br Med J"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0177-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-008-0177-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0177-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:25:12Z","timestamp":1559103912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0177-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,14]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["177"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0177-6","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,14]]}}}